The forum is now full to attend in person. However, registration is still open for live streaming the event online.
|9:00 - 9:15||Welcome|
Mark Wilkinson, Managing Director of SAS UK and Ireland.
|9:15 - 10:00||Keynote address: Sue Forda (European Federation of Pharmaceutical Industries and Associations, Eli Lilly) : "The European Pharmaceutical Industry's drive to responsible clinical trial data sharing"|
|10:00 - 10:20||Andrew Freeman (GSK) – "Sharing clinical trial data to external researchers to foster collaboration and innovation in research and development."|
|10:20 - 10:40||Ulla Outrup (NovoNordisk) – “Clinical Trial Data Transparency at Novo Nordisk”|
|10:40 - 11:00||Coffee break|
|11:15 - 11:45||Sarah Nolan, University Liverpool – "An Academic Researcher's Perspective on Data Transparency"|
|11:45 - 12:30||Panel Discussion|
Strategic aspects of clinical trial data transparency projects : implementation track, benefits, risks, concerns in adopting, lessons learned, perspective of companies that are still considering to join (confirmed participants : Ulla Outrup, VP Clinical NovoNordisk, Sue Forda EFPIA/Eli Lilly, Karla Childers (J&J), Sarah Nolan (University Liverpool), Andrew Freeman (GSK), other participants to be announced.
|12:30 - 13:30||Lunch|
Operational aspects of clinical trial data transparency projects
|13:30 - 14:00||"Overview of J&J agreement with the Yale Open Data Access (YODA) Project"|
Karla Childers, Director of Strategic Projects in the office of the CMO at Johnson & Johnson.
|14:00 - 14:45||3 parallel break-out sessions:|
|14:45 - 15:00||Coffee break and bringing together results of break-out sessions|
|15:00 - 15:20||Gregory Steffens (Novartis): Patient data de-identification in practice|
|15:20 - 16:00||Panel discussion|
Operational aspects of data transparency- Patient data de-identification, data readying and standardization, implication of clinical data management, processes from application to granting access for researcher, analytical tools required.
|16:00 - 16:10||Matt Gross (SAS): "Clinical Trial Data Transparency – summary of the day"|
|16:10 - 16:20||Closing remarks by Bert Boers (SAS) – Vice-President for Southwest Europe, Executive Sponsor Life Sciences EMEA at SAS|
|16:20 - 17:30||Closing Reception: Wine & Cheese.|